Post-Cardiac Arrest Hydrocortisone Use Ameliorates Cardiac Mitochondrial Injury in a Male Rat Model of Ventricular Fibrillation Cardiac Arrest.

Min‐Shan Tsai,Chien‐Hua Huang,Chen‐Hsu Wang,Hsaio‐Ju Cheng,Shih‐Ni Wu,Wei‐Tien Chang,Wen‐Jone Chen

DOI: https://doi.org/10.1161/jaha.120.019837

IF: 6.106

2021-05-09

Journal of the American Heart Association

Abstract:Background Steroid use after cardiac arrest has been reported to improve survival and neurological outcome in cardiac arrest survivors. The study aimed to evaluate the effect of post‐arrest hydrocortisone use on myocardial damage and cardiac mitochondrial injury in a rat model of ventricular fibrillation cardiac arrest. Methods and Results Ventricular fibrillation cardiac arrest was induced and left untreated for 5 minutes in adult male Wistar rats. Cardiopulmonary resuscitation and electric shocks were then applied to achieve return of spontaneous circulation (ROSC). Successfully resuscitated animals were randomized into 3 groups: control, low‐dose hydrocortisone (2 mg/kg), and high‐dose hydrocortisone (8 mg/kg). The low‐dose hydrocortisone and high‐dose hydrocortisone (treatment) groups received intravenous hydrocortisone immediately after ROSC and the control group received saline as placebo. Each group consisted of 15 animals. Within 4 hours of ROSC, both treatment groups showed a higher cardiac output than the control group. At the fourth hour following ROSC, histological examination and transmission electron microscopy demonstrated less myocardial damage and mitochondrial injury in the animals treated with hydrocortisone. In the treatment groups, hydrocortisone mitigated the acceleration of Ca 2+ ‐induced mitochondrial swelling and suppression of complex activity observed in the control group. At the 72nd hour after ROSC, a significantly higher proportion of animals treated with hydrocortisone survived and had good neurological recovery compared with those given a placebo. Conclusions Hydrocortisone use after cardiac arrest may mitigate myocardial injury and cardiac mitochondrial damage and thus improve survival, neurological and histological outcomes in a rat model of ventricular fibrillation cardiac arrest. Nonstandard Abbreviations and Acronyms HE hematoxylin and eosin HSC high‐dose hydrocortisone I/R ischemia/reperfusion LSC low‐dose hydrocortisone ROSC return of spontaneous circulation Sudden cardiac arrest is a challenge to clinical physicians. Extensive efforts have been devoted to improving the quality of cardiopulmonary resuscitation (CPR) and ameliorate post–cardiac arrest syndrome. Even in cases where initial return of spontaneous circulation (ROSC) is achieved under aggressive resuscitation and organized teamwork, the cerebral and myocardial damage along with the systemic ischemia/reperfusion (I/R) injury during CPR result in high in‐hospital mortality and poor neurological recovery. Bundle care following cardiac arrest including ventilation, hemodynamic and targeted temperature management, and emergent coronary angiography as indicated has been proposed to improve the poor prognosis of cardiac arrest survivors. For decades, the use of steroid during the resuscitation and post–cardiac arrest period has been investigated. Relative adrenal insufficiency is common in cardiac arrest survivors with vasopressor‐dependent shock. 1 In both animal and human research, higher serum cortisol has been associated with a higher likelihood of survival and a lower likelihood of death from circulatory shock. 2 , 3 , 4 Several studies, including population‐based analyses and clinical trials, have demonstrated the benefit of steroid administration after ROSC on survival and neurological outcomes. 5 , 6 , 7 , 8 Steroid use after cardiac arrest suppresses inflammatory responses, regulates catecholamine synthesis, and protects against ischemia‐reperfusion injury. 9 The cytokines and immune response after cardiac arrest are similar to sepsis and were once described as sepsis‐like syndrome 10 , 11 until post‐cardiac arrest syndrome was established in 2011. Prol -Abstract Truncated-

cardiac & cardiovascular systems